371 related articles for article (PubMed ID: 16232101)
1. The economic impact of uterine fibroids in the United States: a summary of published estimates.
Mauskopf J; Flynn M; Thieda P; Spalding J; Duchane J
J Womens Health (Larchmt); 2005 Oct; 14(8):692-703. PubMed ID: 16232101
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.
Volkers NA; Hehenkamp WJ; Smit P; Ankum WM; Reekers JA; Birnie E
J Vasc Interv Radiol; 2008 Jul; 19(7):1007-16; quiz 1017. PubMed ID: 18589314
[TBL] [Abstract][Full Text] [Related]
3. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
You JH; Sahota DS; Yuen PM
Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
[TBL] [Abstract][Full Text] [Related]
4. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids.
Dembek CJ; Pelletier EM; Isaacson KB; Spies JB
J Vasc Interv Radiol; 2007 Oct; 18(10):1207-13. PubMed ID: 17911509
[TBL] [Abstract][Full Text] [Related]
5. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
Goldberg J; Bussard A; McNeil J; Diamond J
Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734
[TBL] [Abstract][Full Text] [Related]
6. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
Becker ER
J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
[TBL] [Abstract][Full Text] [Related]
7. Uterine artery embolization as a treatment option for uterine myomas.
Marshburn PB; Matthews ML; Hurst BS
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids.
Beinfeld MT; Bosch JL; Isaacson KB; Gazelle GS
Radiology; 2004 Jan; 230(1):207-13. PubMed ID: 14695395
[TBL] [Abstract][Full Text] [Related]
9. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
Saltiel E
Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
[TBL] [Abstract][Full Text] [Related]
10. Uterine fibroids: a review of health-related quality of life assessment.
Williams VS; Jones G; Mauskopf J; Spalding J; DuChane J
J Womens Health (Larchmt); 2006 Sep; 15(7):818-29. PubMed ID: 16999637
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
Babashov V; Palimaka S; Blackhouse G; O'Reilly D
Ont Health Technol Assess Ser; 2015; 15(5):1-61. PubMed ID: 26357531
[TBL] [Abstract][Full Text] [Related]
12. What are the total costs of surgical treatment for uterine fibroids?
Carls GS; Lee DW; Ozminkowski RJ; Wang S; Gibson TB; Stewart E
J Womens Health (Larchmt); 2008 Sep; 17(7):1119-32. PubMed ID: 18687032
[TBL] [Abstract][Full Text] [Related]
13. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy.
Istre O
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):735-47. PubMed ID: 18328788
[TBL] [Abstract][Full Text] [Related]
14. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
Trials; 2014 Nov; 15():468. PubMed ID: 25432688
[TBL] [Abstract][Full Text] [Related]
15. Uterine artery embolization for the treatment of fibroids.
Topfer LA; Hailey D
Issues Emerg Health Technol; 2002 Aug; (36):1-6. PubMed ID: 12195604
[TBL] [Abstract][Full Text] [Related]
16. Characterization of therapy and costs for patients with uterine fibroids in Utah Medicaid.
Oderda G; Asche C; Jones KP; Merrill RM; Spalding J
Arch Gynecol Obstet; 2007 Sep; 276(3):211-8. PubMed ID: 17342498
[TBL] [Abstract][Full Text] [Related]
17. Health care resource use for uterine fibroid tumors in the United States.
Flynn M; Jamison M; Datta S; Myers E
Am J Obstet Gynecol; 2006 Oct; 195(4):955-64. PubMed ID: 16723104
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of uterine fibromyoma with bilateral uterine artery embolization: state of the art].
Lupattelli T; Clerissi J; Basile A; Minnella DP; Donati Sarti R; Gerli S; Di Renzo G
Minerva Ginecol; 2007 Aug; 59(4):427-39. PubMed ID: 17923833
[TBL] [Abstract][Full Text] [Related]
20. Payer cost savings with endometrial ablation therapy.
London R; Holzman M; Rubin D; Moffitt B
Am J Manag Care; 1999 Jul; 5(7):889-97. PubMed ID: 10557409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
